Tissue microarrays for gene amplification surveys in many different tumor types.
暂无分享,去创建一个
H. Moch | O. Kallioniemi | J. Kononen | L. Bubendorf | G. Sauter | P. Schraml | M. Mihatsch | H. Bissig | A. Nocito | P Schraml | L Bubendorf | G Sauter | M J Mihatsch | H Moch | J Kononen | O P Kallioniemi | A Nocito | H Bissig | H. Moch | L. Bubendorf | M. Mihatsch
[1] K. Czerwenka,et al. Amplification and Expression of the C‐erbB-2 Oncogene in Normal, Hyperplastic, and Malignant Endometria , 1995, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[2] S. Szakáll,et al. Investigation of c-myc oncogene amplification in colorectal cancer. , 1994, Cancer letters.
[3] E. Imyanitov,et al. Amplification of ERBB-2 (HER-2/NEU) oncogene in different neoplasms of patients from USSR. , 1992, Oncology.
[4] R. Makuch,et al. myc family DNA amplification in small cell lung cancer patients' tumors and corresponding cell lines. , 1988, Cancer research.
[5] M. Giacca,et al. Detection of c-erbB-2 amplification in transitional cell bladder carcinoma using competitive PCR technique. , 1996, The Journal of urology.
[6] R. Chaganti,et al. TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines , 1994, International journal of cancer.
[7] J. Foekens,et al. Receptors for hormones and growth factors and (ONCO)‐gene amplification in human ovarian cancer , 1992, International journal of cancer.
[8] Y. Nishiwaki,et al. Role of epidermal growth factor receptor overexpression, K-ras point mutation and c-myc amplification in the carcinogenesis of non-small cell lung cancer. , 1998, Oncology reports.
[9] R. Lidereau,et al. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. , 1994, European journal of cancer. Part B, Oral oncology.
[10] M. Esteller,et al. Detection of clonality and genetic alterations in endometrial pipelle biopsy and its surgical specimen counterpart. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[11] J. Bernaudin,et al. c‐crbB2 gene amplification and protein expression in ovarian epithelial tumors: Evaluation of their respective prognostic significance by multivariate analysis , 1995, International journal of cancer.
[12] N. Hayward,et al. Analysis of gene amplification in head‐and‐neck squamous‐cell carcinomas , 1991, International journal of cancer.
[13] S. Knuutila,et al. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. , 1998, The American journal of pathology.
[14] J. Foekens,et al. Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors. , 1992, European journal of cancer.
[15] M. Fernö,et al. c‐myc amplification is an independent prognostic factor in postmenopausal breast cancer , 1992, International journal of cancer.
[16] S. Baylin,et al. Gene amplification of c-myc and N-myc in small cell carcinoma of the lung. , 1986, Science.
[17] A. El‐Naggar,et al. Heterogeneity of the proliferative fraction and cyclin D1/CCND1 gene amplification in head and neck squamous cell carcinoma. , 1995, Cytometry.
[18] S. Romain,et al. c-myc gene amplification in selected node-negative breast cancer patients correlates with high rate of early relapse. , 1992, European journal of cancer.
[19] H. Battifora. The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[20] A. El‐Naggar,et al. HER-2/neu oncogene characterization in head and neck squamous cell carcinoma. , 1995, Archives of otolaryngology--head & neck surgery.
[21] D. Pinkel,et al. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[22] J. Nesland,et al. Amplification of c-erbB-2, int-2 and c-myc genes in node-negative breast carcinomas. Relationship to prognosis. , 1993, Acta oncologica.
[23] R. Chaganti,et al. Cyclin D1 abnormalities and tobacco exposure in head and neck squamous cell carcinoma , 1996, Head & neck.
[24] F. Bosch,et al. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. , 1994, Cancer research.
[25] P. Gariglio,et al. In vivo amplification and rearrangement of c-myc oncogene in human breast tumors. , 1988, Journal of the National Cancer Institute.
[26] R. Herrmann,et al. Overexpression and amplification of c-myc during progression of human colorectal cancer. , 1996, Oncology.
[27] J. Dong,et al. Quantitative detection of amplification of proto-oncogenes in breast cancer. , 1995, Chinese medical journal.
[28] H. Yokozaki,et al. Frequent Amplification of the Cyclin E Gene in Human Gastric Carcinomas , 1995, Japanese journal of cancer research : Gann.
[29] H. Tesch,et al. Onkogene bei Plattenepithelkarzinomen im Kopf-Hals-Bereich , 1988 .
[30] S. Szakáll,et al. Is the presence of distant metastasis associated with c-myc amplification in gastric cancer? , 1997, Acta chirurgica Hungarica.
[31] X. Zhang,et al. p53 and HER-2 alterations in renal cell carcinoma. , 1997, Urology.
[32] D. Bostwick,et al. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. , 1997, Cancer research.
[33] H. Ito,et al. Alterations of oncogenes in metastatic tumours of human gastric carcinomas. , 1990, British Journal of Cancer.
[34] C. Garrett,et al. Protooncogene amplification and tumor ploidy in human ovarian neoplasms. , 1990, Human pathology.
[35] T. Koda,et al. c-myc Gene amplification in primary stomach cancer. , 1985, Japanese journal of cancer research : Gann.
[36] M. Freeman,et al. Aberrant expression of epidermal growth factor receptor and HER-2 (erbB-2) messenger RNAs in human renal cancers. , 1989, Cancer research.
[37] R. Zeillinger,et al. Cyclin gene amplification and overexpression in breast and ovarian cancers: Evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors , 1996, International journal of cancer.
[38] R. Brown,et al. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis. , 1995, Journal of the National Cancer Institute.
[39] A. Marchetti,et al. Cyclin D1 and retinoblastoma susceptibility gene alterations in non‐small cell lung cancer , 1998, International journal of cancer.
[40] L. Li,et al. A study of c-myc oncogene expression and amplification in colorectal cancer. , 1994, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.
[41] M. Moriyama,et al. [int-2 and c-erbB-2 gene amplification in urological cancers]. , 1992, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.
[42] T. Sugimura,et al. Amplification of the c-myc oncogene in human stomach cancers. , 1984, Gan.
[43] G. Walker,et al. Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets , 1998, Genes, chromosomes & cancer.
[44] P. Terrier,et al. Structure and expression of c-myc and c-fos proto-oncogenes in thyroid carcinomas. , 1988, British Journal of Cancer.
[45] Y. Chung,et al. [Correlation between malignancy of gastric cancer and c-myc DNA amplification or overexpression of c-myc protein]. , 1995, Gan to kagaku ryoho. Cancer & chemotherapy.
[46] 京本 良一. Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma , 1999 .
[47] A. El‐Naggar,et al. PRAD‐1 (CCND1)/Cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma , 1994, Cancer.
[48] M. Beckmann,et al. ERBB2 gene amplification detected by fluorescent differential polymerase chain reaction in paraffin‐embedded breast carcinoma tissues , 1995, International journal of cancer.
[49] T. Strohmeyer,et al. Alterations of the metastasis suppressor gene nm23 and the proto-oncogene c-myc in human testicular germ cell tumors. , 1997, The Journal of urology.
[50] F. Mertens,et al. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression , 1997, Cancer.
[51] P. Quirke,et al. c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma. , 1989, British Journal of Cancer.
[52] P. Heikkilä,et al. Expression patterns of the c-myc gene in adrenocortical tumors and pheochromocytomas. , 1997, The Journal of endocrinology.
[53] M. Maltoni,et al. Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients. , 1990, Cancer research.
[54] Y. Yang. [Expression, amplification and rearrangement of c-myc gene in human thyroid carcinoma]. , 1991, Zhonghua yi xue za zhi.
[55] F. O'Malley,et al. Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast. , 1997, The American journal of pathology.
[56] R. Whyte,et al. Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas. , 1994, The Journal of thoracic and cardiovascular surgery.
[57] A. Marchetti,et al. Cyclin‐d1‐gene amplification and expression in breast carcinoma: Relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21waf1 immunohistochemical expression , 1997, International journal of cancer.
[58] M. Fukumoto,et al. Cyclin‐D1‐gene amplification is a more potent prognostic factor than its protein over‐expression in human head‐and‐neck squamous‐cell carcinoma , 1997, International journal of cancer.
[59] D. Neal,et al. C-erbB-2 in bladder cancer: molecular biology, correlation with epidermal growth factor receptors and prognostic value. , 1996, The Journal of urology.
[60] O. Cussenot,et al. Oncogene amplifications in early‐stage human prostate carcinomas , 1994, International journal of cancer.
[61] M. Noguchi,et al. Amplification of protooncogenes in surgical specimens of human lung carcinomas. , 1989, Cancer research.
[62] C. Sheehan,et al. HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization. , 1997, Human pathology.
[63] E. Hovig,et al. Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas. , 1996, British Journal of Cancer.
[64] J. Lang,et al. Amplification of the C-erbB-2(HER-2/neu) proto-oncogene in ovarian carcinomas. , 1994, Chinese medical journal.
[65] T. Kameda,et al. Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification. , 1990, Cancer research.
[66] S. Hirohashi,et al. Heterogenous amplification of myc family oncogenes in small cell lung carcinoma , 1990, Cancer.
[67] J. Ahomadégbé,et al. Association of c‐erbB2‐gene amplification with poor prognosis in non‐inflammatory breast carcinomas but not in carcinomas of the inflammatory type , 1994, International journal of cancer.
[68] M. Fernö,et al. ERBB2 amplification in breast cancer with a high rate of proliferation. , 1991, Oncogene.
[69] W. Ryder,et al. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. , 1996, British Journal of Cancer.
[70] P. Delrio,et al. High cell kinetics is associated with amplification of the int‐2, bcl‐1, myc and erbB‐2 proto‐oncogenes and loss of heterozygosity at the DF3 locus in primary breast cancers , 1995, International journal of cancer.
[71] E. Schmidt,et al. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[72] J. Cairns,et al. Amplification at chromosome 11q13 in transitional cell tumours of the bladder. , 1991, Oncogene.
[73] V. Gorgoulis,et al. Molecular and immunohistochemical evaluation of epidermal growth factor receptor and c-erb-B-2 gene product in transitional cell carcinomas of the urinary bladder: a study in Greek patients. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[74] G. Wahl,et al. c-myc oncogene copy number in squamous carcinoma of the head and neck. , 1992, American journal of otolaryngology.
[75] I. Weinstein,et al. Expression of cyclins D1 and E in human colon adenocarcinomas. , 1997, Journal of medicine.
[76] J. Bergh,et al. Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer. , 1985, Cancer research.
[77] M. Beckmann,et al. int-2 and c-erbB-2 gene amplification detected in 70 frozen human breast carcinomas by quantitative polymerase chain reaction. , 1997, Anticancer research.
[78] K. Hatch,et al. Oncogene alterations in endometrial carcinoma. , 1990, Gynecologic oncology.
[79] P. Watson,et al. Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis. , 1993, Journal of the National Cancer Institute.
[80] K. Somers,et al. Amplification of the int-2 gene in human head and neck squamous cell carcinomas. , 1990, Oncogene.
[81] E. Schuuring,et al. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification. , 1996, Oncogene.
[82] G. Grillone,et al. Inactivation of p53 and Amplification of Cyclin D1 Correlate With Clinical Outcome in Head and Neck Cancer , 1998, The Laryngoscope.
[83] T. Gilmer,et al. Oncogene amplification in squamous cell carcinoma of the head and neck. , 1990, Archives of otolaryngology--head & neck surgery.
[84] P. Carroll,et al. c-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization. , 1995, The American journal of pathology.
[85] P. Robbins,et al. Detection of c-erbB-2 amplification in breast cancer by in situ hybridization , 1993 .
[86] P. Carroll,et al. Heterogeneity of erbB-2 gene amplification in bladder cancer. , 1993, Cancer research.
[87] J. Kononen,et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.
[88] J. Yokota,et al. Amplification and expression of a cellular oncogene (c-myc) in human gastric adenocarcinoma cells , 1985, Molecular and cellular biology.
[89] S. Pomer,et al. Concomitant overexpression of the EGFR and erbB‐2 genes in renal cell carcinoma (RCC) is correlated with dedifferentiation and metastasis , 1996, International journal of cancer.
[90] Holger Moch,et al. Advances in Brief Survey of Gene Amplifications during Prostate Cancer Progression by High-Throughput Fluorescence in Situ Hybridization on Tissue Microarrays 1 , 1999 .
[91] S. Elledge,et al. Amplification of cyclin genes in colorectal carcinomas. , 1993, Cancer research.
[92] M. Rubin,et al. Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors , 1998, The Prostate.